Solís ArceJSWarrenSSMeriggiNF, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385-1394. doi:10.1038/s41591-021-01454-y.
2.
HussainSFBoylePPatelPSullivanR. Eradicating polio in Pakistan: an analysis of the challenges and solutions to this security and health issue. Global Health. 2016;12(1). doi:10.1186/s12992-016-0195-3.
3.
ImranMKhanSKhanSUddinAKhanMSAmbadeP. COVID -19 situation in Pakistan: a broad overview. Respirology. 2021;26(9):891-892. doi:10.1111/resp.14093.
4.
WangCWangYHanB, et al. Willingness and SARS-CoV-2 vaccination coverage among healthcare workers in china: a nationwide study. Vaccines. 2021;9(9):993. doi:10.3390/vaccines9090993
5.
GargIShekharRSheikhABPalS. COVID-19 Vaccine in pregnant and lactating women: a review of existing evidence and practice guidelines. Infect Dis Rep. 2021;13(3):685-699. doi:10.3390/idr13030064
6.
World Health Organization. Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm: interim guidance, first issued 7 May 2021, updated 28 October 2021. doi:WHO/2019-nCoV/vaccines/SAGE_recommendation/BIBP/2021.2
7.
ShimabukuroTTKimSYMyersTR, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New Engl J Med. 2021;384(24):2273-2282. doi:10.1056/nejmoa2104983.
8.
SolomonYEsheteTMekashaBAssefaW. COVID-19 Vaccine: side effects after the first dose of the oxford AstraZeneca vaccine among health professionals in low-income country: Ethiopia. J Multidiscip Healthc. 2021;14:2577-2585. doi:10.2147/jmdh.s331140.
9.
GazitSShlezingerRPerezG, et al. Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. medRxiv. 2021. doi:10.1101/2021.08.24.21262415.